Does TINZAPARIN Cause Hepatocellular injury? 70 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 70 reports of Hepatocellular injury have been filed in association with TINZAPARIN. This represents 4.1% of all adverse event reports for TINZAPARIN.
70
Reports of Hepatocellular injury with TINZAPARIN
4.1%
of all TINZAPARIN reports
7
Deaths
46
Hospitalizations
How Dangerous Is Hepatocellular injury From TINZAPARIN?
Of the 70 reports, 7 (10.0%) resulted in death, 46 (65.7%) required hospitalization.
Is Hepatocellular injury Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TINZAPARIN. However, 70 reports have been filed with the FAERS database.
What Other Side Effects Does TINZAPARIN Cause?
Acute kidney injury (135)
Anaemia (118)
Off label use (110)
Maternal exposure during pregnancy (108)
Thrombocytopenia (86)
Drug ineffective (82)
Toxic epidermal necrolysis (80)
Premature baby (70)
Cholestasis (67)
Dyspnoea (63)
What Other Drugs Cause Hepatocellular injury?
ACETAMINOPHEN (1,761)
METHOTREXATE (683)
ATORVASTATIN (610)
SULFAMETHOXAZOLE\TRIMETHOPRIM (415)
ENOXAPARIN (365)
TRAMADOL (349)
AMOXICILLIN (347)
ESOMEPRAZOLE (341)
PANTOPRAZOLE (340)
VINCRISTINE (306)
Which TINZAPARIN Alternatives Have Lower Hepatocellular injury Risk?
TINZAPARIN vs TIOCONAZOLE
TINZAPARIN vs TIOPRONIN
TINZAPARIN vs TIOTROPIUM
TINZAPARIN vs TIPIRACIL\TRIFLURIDINE
TINZAPARIN vs TIPRANAVIR